KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) EBT (2016 - 2025)

Historic EBT for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to -$17.8 million.

  • Exact Sciences' EBT rose 5255.69% to -$17.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$994.8 million, marking a year-over-year decrease of 37241.6%. This contributed to the annual value of -$1.0 billion for FY2024, which is 41359.68% down from last year.
  • Latest data reveals that Exact Sciences reported EBT of -$17.8 million as of Q3 2025, which was up 5255.69% from -$57000.0 recorded in Q2 2025.
  • Exact Sciences' 5-year EBT high stood at $1.0 million for Q3 2023, and its period low was -$876.0 million during Q4 2024.
  • Its 5-year average for EBT is -$149.0 million, with a median of -$108.4 million in 2024.
  • Its EBT has fluctuated over the past 5 years, first soared by 10068.67% in 2023, then tumbled by 368849.47% in 2024.
  • Quarter analysis of 5 years shows Exact Sciences' EBT stood at -$224.9 million in 2021, then soared by 42.22% to -$129.9 million in 2022, then soared by 61.23% to -$50.4 million in 2023, then tumbled by 1638.86% to -$876.0 million in 2024, then soared by 97.97% to -$17.8 million in 2025.
  • Its EBT stands at -$17.8 million for Q3 2025, versus -$57000.0 for Q2 2025 and -$101.0 million for Q1 2025.